Patent Applications published on Oct 5, 2017 - page 4

#901
US20170281512A1
Human necessities

COSMETIC POWDER TREATED WITH POLYSACCHARIDE AND METHODS OF MAKING THE SAME

#902 ✅ Patent 9,937,120 granted on 2018-04-10
US20170281513A1
Human necessities

Polyelectrolyte dental adhesives for whitening teeth and teeth components

#903 ✅ Patent 10,383,810 granted on 2019-08-20
US20170281514A1
Human necessities

Inhibiting color fading with layer-by-layer films

#904 ✅ Patent 10,357,668 granted on 2019-07-23
US20170281515A1
Human necessities

Inhibiting color fading with layer-by-layer films

#905 ✅ Patent 9,974,731 granted on 2018-05-22
US20170281516A1
Human necessities

Method for producing functional lubricant and particulate material set used in the method

#906
US20170281517A1
Human necessities

SWEAT-INHIBITING AND/OR DEODORIZING COSMETIC AGENTS WITH LOW EMULSIFIER CONTENT

#907 ✅ Patent 10,675,226 granted on 2020-06-09
US20170281518A1
Human necessities

Lip compositions capable of forming a multilayer structure after application to lips

#908 ✅ Patent 11,185,490 granted on 2021-11-30
US20170281519A1
Human necessities

Cosmetic compositions comprising silicone capable of forming a multilayer structure after application to a keratinous material

#909 ✅ Patent 10,744,074 granted on 2020-08-18
US20170281520A1
Human necessities

Lip compositions

#910 ✅ Patent 11,179,313 granted on 2021-11-23
US20170281521A1
Human necessities

Cosmetic compositions comprising silicone and hydrocarbon capable of forming a multilayer structure after application to a keratinous material

#911 ✅ Patent 11,642,303 granted on 2023-05-09
US20170281522A1
Human necessities

Hair care compositions comprising cationic compounds, starch, and silane compounds

#912 ✅ Patent 10,406,094 granted on 2019-09-10
US20170281523A1
Human necessities

Composition for fast dry of hair

#913
US20170281524A1
Human necessities

COSMETIC HAIRCARE PRODUCT FOR THE STRAIGHTENING OF HAIR IN SHAMPOO FORMAT

#914 ✅ Patent 10,117,826 granted on 2018-11-06
US20170281525A1
Human necessities

Bodily lubricating and moisturizing compositions containing plant mucilage

#915 ✅ Patent 9,918,931 granted on 2018-03-20
US20170281526A1
Human necessities

Method for providing a customized skin care product to a customer

#916
US20170281527A1
Human necessities

MINERAL BASED COMPOSITIONS AND USE THEREOF

#917
US20170281528A1
Human necessities

Hair Follicles Made Ex Vivo That Can be Inserted into a Recipient for Hair Restoration

#918
US20170281529A1
Human necessities

Formulations

#919
US20170281530A1
Human necessities

SYSTEMS AND METHODS FOR PRODUCING HOMOGENOUS PHARMACEUTICAL COMPOSITIONS

#920 ✅ Patent 10,251,835 granted on 2019-04-09
US20170281531A1
Human necessities

Cranial delivery of pharmaceuticals

#921 ✅ Patent 10,174,053 granted on 2019-01-08
US20170281532A1
Human necessities

2 substituted cephem compounds

#922 ✅ Patent 9,980,900 granted on 2018-05-29
US20170281533A1
Human necessities

Intravenous administration of tramadol

#923
US20170281534A1
Human necessities

ADMINISTRATION OF INTRAVENOUS IBUPROFEN

#924
US20170281535A1
Human necessities

METHOD AND DEVICE FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE USING A MICROPROJECTION ARRAY

#925
US20170281536A1
Human necessities

DEGRADABLE NETWORKS FOR SUSTAINED RELEASE AND CONTROLLED RELEASE DEPOT DRUG DELIVERY APPLICATIONS

#926
US20170281537A1
Human necessities

LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT

#927 ✅ Patent 9,889,089 granted on 2018-02-13
US20170281538A1
Human necessities

Dietary supplement non-fluoride toothpaste and methods of making and using same

#928 ✅ Patent 10,463,612 granted on 2019-11-05
US20170281539A1
Human necessities

Method for manufacturing medicated chewing gum without cooling

#929
US20170281540A1
Human necessities

COMPOSITION OF MATTER COMPRISING LIPOSOMES EMBEDDED IN A POLYMERIC MATRIX AND METHODS OF USING SAME

#930
US20170281541A1
Human necessities

LIPOSOME-BASED MUCUS-PENETRATING PARTICLES FOR MUCOSAL DELIVERY

#931 ✅ Patent 10,052,284 granted on 2018-08-21
US20170281542A1
Human necessities

Lipid formulations for delivery of messenger RNA

#932 ✅ Patent 10,485,760 granted on 2019-11-26
US20170281543A1
Human necessities

Method for producing liposome

#933 ✅ Patent 9,980,909 granted on 2018-05-29
US20170281544A1
Human necessities

Oxygen-enabled composition

#934 ✅ Patent 10,751,286 granted on 2020-08-25
US20170281545A1
Human necessities

Immunomodulation using spores and pollen grains

#935 ✅ Patent 9,907,754 granted on 2018-03-06
US20170281546A1
Human necessities

Taurine compositions suitable for inhalation

#936 ✅ Patent 9,943,483 granted on 2018-04-17
US20170281547A1
Human necessities

Preparation of peptide loaded PLGA microspheres with controlled release characteristics

#937
US20170281548A1
Human necessities

Organic Compounds

#938 ✅ Patent 10,357,459 granted on 2019-07-23
US20170281549A1
Human necessities

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

#939
US20170281550A1
Human necessities

COMPRESSIBLE AND FREE-FLOW CO-AGGLOMERATES OF MANNITOL AND GRANULAR STARCH

#940
US20170281551A1
Human necessities

SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION

#941 ✅ Patent 10,772,838 granted on 2020-09-15
US20170281552A1
Human necessities

Powdery material mixing degree measurement device, powdery material mixing and feeding system, and compression-molding machine including the same

#942 ✅ Patent 10,159,650 granted on 2018-12-25
US20170281553A1
Human necessities

Film coating composition and methods of making and using the same

#943
US20170281554A1
Human necessities

SYSTEM FOR UPPER INTESTINAL DELIVERY OF ACTIVE INGREDIENTS

#944 ✅ Patent 10,182,990 granted on 2019-01-22
US20170281555A1
Human necessities

Gastric reflux resistant dosage forms

#945 ✅ Patent 10,172,802 granted on 2019-01-08
US20170281556A1
Human necessities

Oral pharmaceutical dosage forms of budesonide

#946 ✅ Patent 10,098,846 granted on 2018-10-16
US20170281557A1
Human necessities

Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment

#947
US20170281558A1
Human necessities

ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR THE MODIFIED RELEASE OF ACTIVE PRINCIPLE(S).

#948 ✅ Patent 11,471,422 granted on 2022-10-18
US20170281559A1
Human necessities

Stealth, targeted nanoparticles (STN) for oral drug delivery

#949
US20170281560A1
Human necessities

SYSTEMS AND METHODS OF ON-DEMAND CUSTOMIZED MEDICAMENT DOSES BY 3D PRINTING

#950
US20170281561A1
Human necessities

DRUG DELIVERY FABRIC HAVING DRUG-CONTAINING LAYER

#951 ✅ Patent 10,729,686 granted on 2020-08-04
US20170281562A1
Human necessities

Pharmaceutical compositions

#952 ✅ Patent 10,369,118 granted on 2019-08-06
US20170281563A1
Human necessities

Method of reducing scarring

#953
US20170281564A1
Human necessities

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD

#954
US20170281565A1
Human necessities

Composition for Administering an NMDA Receptor Antagonist to a Subject

#955
US20170281566A1
Human necessities

COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

#956 ✅ Patent 10,265,279 granted on 2019-04-23
US20170281567A1
Human necessities

Combinations of LSD1 inhibitors for use in the treatment of solid tumors

#957 ✅ Patent 10,357,465 granted on 2019-07-23
US20170281568A1
Human necessities

Eutectic formulations of cyclobenzaprine hydrochloride

#958
US20170281569A1
Human necessities

METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY

#959 ✅ Patent 10,098,857 granted on 2018-10-16
US20170281570A1
Human necessities

Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds

#960
US20170281571A1
Human necessities

METHODS FOR THE TREATMENT OF ROSACEA

#961 ✅ Patent 10,849,868 granted on 2020-12-01
US20170281572A1
Human necessities

Formulation for treating chronic wounds

#962
US20170281573A1
Human necessities

MEDICINAL COMPOSITION FOR ENHANCED DELIVERY OF TRITERPENES

#963 ✅ Patent 10,028,906 granted on 2018-07-24
US20170281574A1
Human necessities

Method and kit for treating a solid tumor and associated desmoplasia

#964
US20170281575A1
Human necessities

BLT2 AGONISTS FOR THE TREATMENT OF PAIN

#965 ✅ Patent 10,039,731 granted on 2018-08-07
US20170281576A1
Human necessities

Treatment of cancer with specific RXR agonists

#966 ✅ Patent 10,188,618 granted on 2019-01-29
US20170281577A1
Human necessities

Treatment of cancer with specific RXR agonists

#967
US20170281578A1
Human necessities

METHODS FOR TREATING METABOLIC DISTURBANCES

#968 ✅ Patent 10,525,024 granted on 2020-01-07
US20170281579A1
Human necessities

Methods for rescuing phenobarbital-resistance of seizures by ANA-12 or ANA-12 in combination with CLP290

#969 ✅ Patent 11,000,495 granted on 2021-05-11
US20170281580A1
Human necessities

Topical diclofenac sodium compositions

#970 ✅ Patent 10,688,069 granted on 2020-06-23
US20170281581A1
Human necessities

Sports health performance composition

#971
US20170281582A1
Human necessities

ENHANCER FOR EATING ACTIVITY AND/OR GASTROINTESTINAL ACTIVITY

#972 ✅ Patent 10,111,843 granted on 2018-10-30
US20170281583A1
Human necessities

Methods for treating brain injury

#973
US20170281584A1
Human necessities

Misoprostol Dispersible Tablet

#974
US20170281585A1
Human necessities

METHODS FOR THE TREATMENT OF SIALORRHEA

#975
US20170281586A1
Human necessities

SOLID MOLECULAR DISPERSION OF FESOTERODINE HYDROGEN FUMARATE AND POLYMERIC BINDER

#976
US20170281587A1
Human necessities

ERYTHROCYTE FUNCTION IMPROVING AGENT

#977 ✅ Patent 10,265,294 granted on 2019-04-23
US20170281588A1
Human necessities

Compositions and methods for treating epithelial cancer

#978 ✅ Patent 10,045,961 granted on 2018-08-14
US20170281589A1
Human necessities

Use of sting agonists to treat chronic hepatitis B virus infection

#979 ✅ Patent 10,130,607 granted on 2018-11-20
US20170281590A1
Human necessities

Methods of reducing blood lactate concentration

#980 ✅ Patent 10,188,629 granted on 2019-01-29
US20170281591A1
Human necessities

Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis

#981 ✅ Patent 11,033,529 granted on 2021-06-15
US20170281592A1
Human necessities

Method of treating neurodegenerative disorders

#982
US20170281593A1
Human necessities

Methods of Treating Fatty Liver Disease

#983 ✅ Patent 10,722,493 granted on 2020-07-28
US20170281594A1
Human necessities

Methods for treating fibroproliferative disorders in a mammal

#984
US20170281595A1
Human necessities

FORMULATION AND METHOD TO INDUCE A DEEP STATE OF RELAXATION

#985
US20170281596A1
Human necessities

PHARMACEUTICAL COMBINATION CONTAINING AN ANALGESIC AGENT AND AN ANTISPASMODIC AGENT

#986 ✅ Patent 10,092,542 granted on 2018-10-09
US20170281597A1
Human necessities

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

#987 ✅ Patent 10,010,531 granted on 2018-07-03
US20170281598A1
Human necessities

Methods and compositions for treating clostridium difficile associated disease

#988
US20170281599A1
Human necessities

AMORPHOUS FORM OF DACLATASVIR AND ITS SALTS AND PROCESS FOR PREPARATION THEREOF

#989 ✅ Patent 10,010,534 granted on 2018-07-03
US20170281600A1
Human necessities

Intravenous formulation and LC/MS/MS analysis method for GMC1

#990 ✅ Patent 10,183,012 granted on 2019-01-22
US20170281601A1
Human necessities

Compounds and compositions and methods of use

#991
US20170281602A1
Human necessities

SOLID FORMS OF (S)-2-METHOXY-3--PROPIONIC ACID AND OF SALTS THEREOF

#992 ✅ Patent 11,135,202 granted on 2021-10-05
US20170281603A1
Human necessities

Thiazolide compounds for treating viral infections

#993 ✅ Patent 10,028,940 granted on 2018-07-24
US20170281604A1
Human necessities

Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders

#994 ✅ Patent 9,956,206 granted on 2018-05-01
US20170281605A1
Human necessities

Compositions and methods for treating amyotrophic lateral sclerosis in responders

#995 ✅ Patent 9,949,958 granted on 2018-04-24
US20170281606A1
Human necessities

Methods of treating hepatic encephalopathy

#996
US20170281607A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES

#997
US20170281608A1
Human necessities

Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions

#998 ✅ Patent 10,188,637 granted on 2019-01-29
US20170281609A1
Human necessities

Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same

#999 ✅ Patent 9,931,328 granted on 2018-04-03
US20170281610A1
Human necessities

Topical retinoid compositions

#1000
US20170281611A1
Human necessities

QUINOLINES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-CAUSED DISEASES

#1001
US20170281612A1
Human necessities

Methods for the Treatment of Cystic Fibrosis

#1002 ✅ Patent 9,993,470 granted on 2018-06-12
US20170281613A1
Human necessities

Combination therapy

#1003
US20170281614A1
Human necessities

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS

#1004 ✅ Patent 10,624,888 granted on 2020-04-21
US20170281615A1
Human necessities

Extended release, abuse deterrent dosage forms

#1005 ✅ Patent 10,022,370 granted on 2018-07-17
US20170281616A1
Human necessities

Morphinan compounds

#1006 ✅ Patent 10,105,361 granted on 2018-10-23
US20170281617A1
Human necessities

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#1007 ✅ Patent 9,827,241 granted on 2017-11-28
US20170281618A1
Human necessities

Injectable flowable composition comprising buprenorphine

#1008 ✅ Patent 11,413,282 granted on 2022-08-16
US20170281619A1
Human necessities

Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor

#1009
US20170281620A1
Human necessities

CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY

#1010 ✅ Patent 10,076,519 granted on 2018-09-18
US20170281621A1
Human necessities

Substituted pyridazines as skeletal muscle modulators

#1011
US20170281622A1
Human necessities

DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK

#1012 ✅ Patent 10,004,741 granted on 2018-06-26
US20170281623A1
Human necessities

Solid forms of an epidermal growth factor receptor kinase inhibitor

#1013
US20170281624A1
Human necessities

COMBINATION THERAPIES OF ALK INHIBITORS

#1014 ✅ Patent 10,058,550 granted on 2018-08-28
US20170281625A1
Human necessities

Methods of treating heart failure

#1015
US20170281626A1
Human necessities

PYRIMIDINEDIONE COMPOUNDS

#1016 ✅ Patent 10,285,990 granted on 2019-05-14
US20170281627A1
Human necessities

Toll like receptor modulator compounds

#1017 ✅ Patent 10,071,097 granted on 2018-09-11
US20170281628A1
Human necessities

Molecular targets for the treatment of wounds, in particular chronic wounds

#1018 ✅ Patent 10,143,693 granted on 2018-12-04
US20170281629A1
Human necessities

Dosing regimen for missed doses for long-acting injectable paliperidone esters

#1019 ✅ Patent 10,786,504 granted on 2020-09-29
US20170281630A1
Human necessities

Method of treatment and compositions comprising a dual PI3K delta-gamma kinase inhibitor and a corticosteroid

#1020 ✅ Patent 10,449,195 granted on 2019-10-22
US20170281631A1
Human necessities

Pharmaceutical formulation of palbociclib and a preparation method thereof

#1021 ✅ Patent 10,045,991 granted on 2018-08-14
US20170281632A1
Human necessities

Methods of treating pediatric cancers

#1022 ✅ Patent 10,576,085 granted on 2020-03-03
US20170281633A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#1023
US20170281634A1
Human necessities

MINDFULLNESS-INCREASING COMPOSITION AND METHOD OF USE

#1024 ✅ Patent 10,166,236 granted on 2019-01-01
US20170281635A1
Human necessities

Pharmaceutical formulations comprising substituted pyrazolo[5,1-c]pyrido[4,3-e][1,2,4]triazines for treating lysosomal storage disorders

#1025
US20170281636A1
Human necessities

ANTIVIRAL THERAPY

#1026 ✅ Patent 10,034,884 granted on 2018-07-31
US20170281637A1
Human necessities

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#1027 ✅ Patent 10,004,750 granted on 2018-06-26
US20170281638A1
Human necessities

Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof

#1028 ✅ Patent 9,949,982 granted on 2018-04-24
US20170281639A1
Human necessities

Preparation containing cephalosporin having a catechol moiety

#1029
US20170281640A1
Human necessities

Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)

#1030
US20170281641A1
Human necessities

CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS

#1031
US20170281642A1
Human necessities

METHODS OF TREATING ACUTE MYELOID LEUKEMIA OR ACUTE LYMPHOID LEUKEMIA USING PHARMACEUTICAL COMPOSITIONS CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

#1032 ✅ Patent 10,517,877 granted on 2019-12-31
US20170281643A1
Human necessities

Compounds and methods for modulating frataxin expression

#1033 ✅ Patent 10,258,631 granted on 2019-04-16
US20170281644A1
Human necessities

Formulations of testosterone and methods of treatment therewith

#1034 ✅ Patent 9,931,349 granted on 2018-04-03
US20170281645A1
Human necessities

Steroid hormone pharmaceutical composition

#1035
US20170281646A1
Human necessities

STEROID HORMONE PHARMACEUTICAL COMPOSITION

#1036
US20170281647A1
Human necessities

STEROID HORMONE COMPOSITIONS IN MEDIUM CHAIN OILS

#1037
US20170281648A1
Human necessities

DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE

#1038 ✅ Patent 10,195,213 granted on 2019-02-05
US20170281649A1
Human necessities

Chemical entities that kill senescent cells for use in treating age-related disease

#1039
US20170281650A1
Human necessities

USE OF DIHYDROCHOLESTEROL

#1040
US20170281651A1
Human necessities

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A OR STEROIDOGENESIS INHIBITORS

#1041
US20170281652A1
Human necessities

Therapeutic Compositions and Methods

#1042
US20170281653A1
Human necessities

DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES

#1043 ✅ Patent 9,949,993 granted on 2018-04-24
US20170281654A1
Human necessities

Compositions for administration of zoledronic acid or related compounds for treating low back pain

#1044 ✅ Patent 9,861,648 granted on 2018-01-09
US20170281655A1
Human necessities

Osteoclast inhibitors for knee conditions

#1045 ✅ Patent 9,956,237 granted on 2018-05-01
US20170281656A1
Human necessities

Osteoclast inhibitors for knee conditions

#1046
US20170281657A1
Human necessities

Low Osmolality Gel Composition

#1047 ✅ Patent 9,956,239 granted on 2018-05-01
US20170281658A1
Human necessities

Methods of treating retroviral infections and related dosage regimes

#1048 ✅ Patent 10,130,645 granted on 2018-11-20
US20170281659A1
Human necessities

Use of thiopyrimidinecarboxamide for treating cancer

#1049
US20170281660A1
Human necessities

TOPICAL COMPOSITION FOR REDUCING PATHOGEN BINDING

#1050 ✅ Patent 10,660,910 granted on 2020-05-26
US20170281661A1
Human necessities

Use of sedoheptulose for prevention or treatment of inflammation

#1051 ✅ Patent 10,610,597 granted on 2020-04-07
US20170281662A1
Human necessities

Polycarbonates bearing aromatic N-heterocycles for drug delivery

#1052
US20170281663A1
Human necessities

TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS

#1053 ✅ Patent 11,033,565 granted on 2021-06-15
US20170281664A1
Human necessities

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#1054 ✅ Patent 10,744,148 granted on 2020-08-18
US20170281665A1
Human necessities

Methods of treating breast cancer that overexpress AKT kinase

#1055 ✅ Patent 11,291,683 granted on 2022-04-05
US20170281666A1
Human necessities

Bilayer tablets of B vitamins and process for preparing the same

#1056 ✅ Patent 11,207,343 granted on 2021-12-28
US20170281667A1
Human necessities

Compositions and therapeutic methods

#1057
US20170281668A1
Human necessities

MATERIALS AND METHODS FOR PREVENTING AND TREATING MICROBE-MEDIATED EPITHELIAL DISORDERS

#1058 ✅ Patent 10,226,482 granted on 2019-03-12
US20170281669A1
Human necessities

Copolymer and method for treatment of bacterial infection

#1059 ✅ Patent 10,828,321 granted on 2020-11-10
US20170281670A1
Human necessities

Redox signaling gel formulation

#1060
US20170281671A1
Human necessities

NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS

#1061 ✅ Patent 10,080,768 granted on 2018-09-25
US20170281672A1
Human necessities

Systems and methods for delivery of peptides

#1062
US20170281673A1
Human necessities

USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS

#1063
US20170281674A1
Human necessities

Process For Generating Nanometer Sized Particles That Increase Oxygen Levels In Mammalian Tissues

#1064 ✅ Patent 9,801,906 granted on 2017-10-31
US20170281675A1
Human necessities

Oxygen-enabled fluid

#1065
US20170281676A1
Human necessities

HIV-CURE

#1066
US20170281677A1
Human necessities

THERAPEUTIC COMPOSITION FOR VARIOUS SKIN CONDITIONS

#1067 ✅ Patent 10,864,231 granted on 2020-12-15
US20170281678A1
Human necessities

Botulinum toxin and colloidal silver particles

#1068 ✅ Patent 10,357,512 granted on 2019-07-23
US20170281679A1
Human necessities

Method for preparing universal plasma

#1069
US20170281680A1
Human necessities

Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection

#1070
US20170281681A1
Human necessities

POOLED NK CELLS FROM UMBILICAL CORD BLOOD ASSOCIATED WITH ANTIBODIES AND THEIR USES FOR THE TREATMENT OF DISEASE

#1071
US20170281682A1
Human necessities

CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY

#1072
US20170281683A1
Human necessities

GLYPICAN-3 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY

#1073 ✅ Patent 10,363,274 granted on 2019-07-30
US20170281684A1
Human necessities

Renal cell populations and uses thereof

#1074
US20170281685A1
Human necessities

NOBLE GAS AUGMENTATION OF REGENERATIVE CELL ACTIVITY

#1075
US20170281686A1
Human necessities

BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF

#1076 ✅ Patent 10,231,998 granted on 2019-03-19
US20170281687A1
Human necessities

Method for chemoselection

#1077 ✅ Patent 10,363,277 granted on 2019-07-30
US20170281688A1
Human necessities

Synthetic rhinoceros horn analogues

#1078 ✅ Patent 10,463,699 granted on 2019-11-05
US20170281689A1
Human necessities

Fish oil topical composition

#1079 ✅ Patent 11,045,503 granted on 2021-06-29
US20170281690A1
Human necessities

Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis

#1080 ✅ Patent 10,426,823 granted on 2019-10-01
US20170281691A1
Human necessities

Methods for constructing antibiotic resistance free vaccines

#1081 ✅ Patent 10,471,107 granted on 2019-11-12
US20170281692A1
Human necessities

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#1082 ✅ Patent 10,493,111 granted on 2019-12-03
US20170281693A1
Human necessities

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#1083
US20170281694A1
Human necessities

TOPICAL CLEANSING COMPOSITION WITH PREBIOTIC/PROBIOTIC ADDITIVE

#1084 ✅ Patent 10,874,700 granted on 2020-12-29
US20170281695A1
Human necessities

Sanitizer composition with probiotic/prebiotic active ingredient

#1085 ✅ Patent 10,610,552 granted on 2020-04-07
US20170281696A1
Human necessities

Nutrient rich germinant composition and spore incubation method

#1086 ✅ Patent 9,855,305 granted on 2018-01-02
US20170281697A1
Human necessities

Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors

#1087 ✅ Patent 10,300,094 granted on 2019-05-28
US20170281698A1
Human necessities

Method and composition for inhibiting bacterial adhesion of oral pathogens

#1088 ✅ Patent 10,086,025 granted on 2018-10-02
US20170281699A1
Human necessities

Method of identifying a biologically-active composition from a biofilm

#1089
US20170281700A1
Human necessities

PHAGE THERAPY FOR TARGETING ENTEROCOCCI

#1090
US20170281701A1
Human necessities

Formulation for the Nebulization of Oil Based Substances Suitable for Use with a Vibrating Mesh Nebulizer

#1091 ✅ Patent 10,537,601 granted on 2020-01-21
US20170281702A1
Human necessities

Method of isolating anti-viral ingredients from , compositions comprising them and their medical use

#1092
US20170281703A1
Human necessities

NUTRITIONAL SUPPLEMENT AND RELATED METHOD FOR ACTIVATING A SUBJECT'S ANTIOXIDANT SYSTEM

#1093
US20170281704A1
Human necessities

ANTI DENGUE ACTIVITY OF CISSAMPELOS PAREIRA EXTRACTS

#1094
US20170281705A1
Human necessities

ANTI-VIRAL THERAPEUTIC COMPOSITIONS

#1095 ✅ Patent 10,226,502 granted on 2019-03-12
US20170281706A1
Human necessities

Sugar extract

#1096 ✅ Patent 10,576,121 granted on 2020-03-03
US20170281707A1
Human necessities

Composition and method for the treatment of menopause

#1097 ✅ Patent 10,016,478 granted on 2018-07-10
US20170281708A1
Human necessities

Combinations of extracts of serenoa repens and lipophilic extracts of zingiber officinalis and echinacea angustifolia, the use thereof, and formulations containing them

#1098 ✅ Patent 10,406,207 granted on 2019-09-10
US20170281709A1
Human necessities

Peptide conjugates of GLP-1 receptor agonists and gastrin and their use

#1099
US20170281710A1
Human necessities

USE OF INHIBITORS OF BINDING BETWEEN A PAR-1 RECEPTOR AND ITS LIGANDS FOR THE TREATMENT OF GLIOMA

#1100 ✅ Patent 10,307,455 granted on 2019-06-04
US20170281711A1
Human necessities

Activin type 2 receptor antibodies

#1101 ✅ Patent 10,064,909 granted on 2018-09-04
US20170281712A1
Human necessities

Compositions and methods for chronic use of a weight-gaining compound

#1102
US20170281713A1
Human necessities

A METHOD FOR SIDE EFFECT REDUCTION IN THE USE OF STATINS VIA PHYSIOLOGICALLY SYNTHESIZED GLUTATHIONE

#1103
US20170281714A1
Human necessities

METHOD OF TREATMENT USING LIPOSOMALLY FORMULATED REDUCED GLUTATHIONE TO COOPERATE WITH IL-10 TO MODULATE INFLAMMATORY RESPONSE TRIGGERED IN HIV+ AND TB IMMUNE-COMPROMISED DIABETIC PATIENTS

#1104 ✅ Patent 10,028,994 granted on 2018-07-24
US20170281715A1
Human necessities

Memory or learning improvement using peptide and other compositions

#1105 ✅ Patent 10,744,179 granted on 2020-08-18
US20170281716A1
Human necessities

Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing

#1106 ✅ Patent 10,806,769 granted on 2020-10-20
US20170281717A1
Human necessities

Antimicrobial peptide stimulating cleansing composition

#1107
US20170281718A1
Human necessities

ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION

#1108
US20170281719A1
Human necessities

Sincalide Formulations

#1109 ✅ Patent 10,213,477 granted on 2019-02-26
US20170281720A1
Human necessities

Peptidomimetic macrocycles

#1110 ✅ Patent 10,265,374 granted on 2019-04-23
US20170281721A1
Human necessities

Occidiofungin formations and uses thereof

#1111
US20170281722A1
Human necessities

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#1112 ✅ Patent 10,456,443 granted on 2019-10-29
US20170281723A1
Human necessities

Peptidyl calcineurin inhibitors

#1113
US20170281724A9
Human necessities

USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES

#1114 ✅ Patent 10,525,104 granted on 2020-01-07
US20170281725A1
Human necessities

Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer

#1115 ✅ Patent 9,974,829 granted on 2018-05-22
US20170281726A1
Human necessities

Methods and uses of slit for treating fibrosis

#1116
US20170281727A1
Human necessities

THERAPEUTIC OR PROPHYLACTIC AGENT FOR ITCHING SKIN DISEASES

#1117
US20170281728A1
Human necessities

METHOD FOR TREATING CANCER USING TETRADRINE

#1118 ✅ Patent 11,219,667 granted on 2022-01-11
US20170281729A1
Human necessities

Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1A

#1119 ✅ Patent 10,716,832 granted on 2020-07-21
US20170281730A1
Human necessities

Compositions and methods for the systemic treatment of arthritis

#1120
US20170281731A1
Human necessities

UNITARY COMBINATION OF FSH AND HCG

#1121
US20170281732A1
Human necessities

METHODS OF TREATING MILD BRAIN INJURY

#1122 ✅ Patent 10,117,909 granted on 2018-11-06
US20170281733A1
Human necessities

Combination of an insulin and a GLP-1 agonist

#1123 ✅ Patent 10,786,554 granted on 2020-09-29
US20170281734A1
Human necessities

Factor VIII polypeptide formulations

#1124 ✅ Patent 10,517,934 granted on 2019-12-31
US20170281735A1
Human necessities

Compositions and methods for the treatment of photoaging and other conditions

#1125 ✅ Patent 10,130,688 granted on 2018-11-20
US20170281736A1
Human necessities

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#1126
US20170281737A1
Human necessities

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

#1127 ✅ Patent 10,646,555 granted on 2020-05-12
US20170281738A1
Human necessities

Compositions and methods relating to argininosuccinate synthetase

#1128 ✅ Patent 10,980,866 granted on 2021-04-20
US20170281739A1
Human necessities

Alpha-1 anti-trypsin for treating liver diseases

#1129
US20170281740A1
Human necessities

SERODIAGNOSIS OF SALMON POISONING DISEASE

#1130 ✅ Patent 10,744,184 granted on 2020-08-18
US20170281741A1
Human necessities

FGF-23 epitope peptides and methods of use thereof

#1131 ✅ Patent 10,441,644 granted on 2019-10-15
US20170281742A1
Human necessities

H3.3 CTL peptides and uses thereof

#1132 ✅ Patent 10,744,158 granted on 2020-08-18
US20170281743A1
Human necessities

Th1 vaccination priming for active immunotherapy

#1133
US20170281744A1
Human necessities

METHOD OF TREATMENT

#1134 ✅ Patent 10,279,025 granted on 2019-05-07
US20170281745A1
Human necessities

LPS vaccine

#1135 ✅ Patent 10,183,071 granted on 2019-01-22
US20170281746A1
Human necessities

Interaction of moraxella catarrhalis with epithellal cells, extracellular matrix proteins and the complement system

#1136 ✅ Patent 10,071,151 granted on 2018-09-11
US20170281747A1
Human necessities

Therapeutic HPV16 vaccines

#1137 ✅ Patent 10,258,685 granted on 2019-04-16
US20170281748A1
Human necessities

Multi-CBV vaccine for preventing or treating type I diabetes

#1138 ✅ Patent 10,232,034 granted on 2019-03-19
US20170281749A1
Human necessities

Compositions comprising CH505 envelopes, and trimers

#1139 ✅ Patent 10,034,933 granted on 2018-07-31
US20170281750A1
Human necessities

HIV and immunogenic peptide sequences and compositions

#1140
US20170281751A1
Human necessities

EQUINE DISEASE MODEL FOR HERPESVIRUS NEUROLOGIC DISEASE AND USES THEREOF

#1141 ✅ Patent 10,925,960 granted on 2021-02-23
US20170281752A1
Human necessities

Antigen delivery system

#1142 ✅ Patent 10,004,803 granted on 2018-06-26
US20170281753A1
Human necessities

Low, immune enhancing, dose mtor inhibitors and uses thereof

#1143 ✅ Patent 10,512,687 granted on 2019-12-24
US20170281754A1
Human necessities

Compositions and methods for enhanced innate immunity

#1144 ✅ Patent 10,238,737 granted on 2019-03-26
US20170281755A1
Human necessities

Oral administration of at least one pharmaceutical and/or antigenic active substance

#1145
US20170281756A1
Human necessities

COMPOSITIONS AND METHODS TO SELECTIVELY BLOCK PAIN INDUCED BY COLD

#1146
US20170281757A1
Human necessities

PROBIOTICS, SECRETORY IgA AND INFECTION

#1147
US20170281758A1
Human necessities

CALICHEAMICIN ANTIBODY DRUG CONJUGATES LINKING AN AMIDOACETYL GROUP TO A SUGAR MOIETY ON CALICHEAMICIN

#1148 ✅ Patent 10,471,141 granted on 2019-11-12
US20170281759A1
Human necessities

Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity

#1149 ✅ Patent 10,869,923 granted on 2020-12-22
US20170281760A1
Human necessities

Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota

#1150 ✅ Patent 9,913,900 granted on 2018-03-13
US20170281761A1
Human necessities

Method of treating alvelor bone loss through the use of anti-sclerostin antibodies

#1151 ✅ Patent 11,278,618 granted on 2022-03-22
US20170281762A1
Human necessities

Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients

#1152 ✅ Patent 9,968,675 granted on 2018-05-15
US20170281763A1
Human necessities

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

#1153 ✅ Patent 10,537,633 granted on 2020-01-21
US20170281764A1
Human necessities

Antibodies to TIGIT

#1154 ✅ Patent 10,058,609 granted on 2018-08-28
US20170281765A1
Human necessities

Antigen binding proteins that bind PD-L1

#1155 ✅ Patent 10,603,380 granted on 2020-03-31
US20170281766A1
Human necessities

Chimeric antigen and T cell receptors and methods of use

#1156 ✅ Patent 10,245,321 granted on 2019-04-02
US20170281767A1
Human necessities

Combination therapy for inducing immune response to disease

#1157
US20170281768A1
Human necessities

NOVEL NUCLEIC ACID MOLECULES WITH ANTITUMORAL ACTIVITY

#1158
US20170281769A1
Human necessities

STABLE ANTI-IL-4Ra FORMULATION

#1159 ✅ Patent 10,603,381 granted on 2020-03-31
US20170281770A1
Human necessities

Synthesis of nanocompounds comprising anatase-phase titanium oxide and compositions containing same for the treatment of cancer

#1160
US20170281771A1
Human necessities

METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS

#1161
US20170281772A1
Human necessities

A NEURAL SUBSTRATE FOR SUGAR PREFERENCE

#1162 ✅ Patent 10,391,175 granted on 2019-08-27
US20170281773A1
Human necessities

BET bromodomain inhibitors and therapeutic methods using the same

#1163
US20170281774A1
Human necessities

LINACLOTIDE COMPOSITIONS

#1164
US20170281775A1
Human necessities

MODIFICATIONS OF SOLID 3-SN-PHOSPHOGLYCERIDES

#1165 ✅ Patent 10,286,077 granted on 2019-05-14
US20170281776A1
Human necessities

Steroid hormone compositions in medium chain oils

#1166
US20170281777A1
Human necessities

LIQUID CONCENTRATED VITAMIN E COMPOSITIONS

#1167 ✅ Patent 10,898,575 granted on 2021-01-26
US20170281778A1
Human necessities

Long-acting polymeric delivery systems

#1168
US20170281779A1
Human necessities

METHOD OF TREATING PATIENTS NON-RESPONSIVE TO PALONOSETRON

#1169 ✅ Patent 10,471,152 granted on 2019-11-12
US20170281780A1
Human necessities

Colloidal dispersion comprising HPMCAS

#1170 ✅ Patent 10,888,621 granted on 2021-01-12
US20170281781A1
Human necessities

Injectable tissue adhesive hydrogel including gamma-cyclodextrin and biomedical use thereof

#1171 ✅ Patent 10,918,726 granted on 2021-02-16
US20170281782A1
Human necessities

Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system

#1172 ✅ Patent 10,279,045 granted on 2019-05-07
US20170281783A1
Human necessities

Low protein percentage gelling compositions

#1173
US20170281784A1
Human necessities

PROTEIN-PROTEIN INTERACTION INDUCING TECHNOLOGY

#1174
US20170281785A1
Human necessities

GLYCEROL LINKED PEGYLATED SUGARS AND GLYCOPEPTIDES

#1175
US20170281786A1
Human necessities

COMPOSITIONS AND METHODS OF MAKING RAPIDLY DISSOLVING IONICALLY MASKED FORMULATIONS

#1176
US20170281787A1
Human necessities

CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERSES THE BLOOD-BRAIN BARRIER, AND A CYTOTOXIN

#1177 ✅ Patent 10,232,020 granted on 2019-03-19
US20170281788A1
Human necessities

Incretin-insulin conjugates

#1178 ✅ Patent 10,207,005 granted on 2019-02-19
US20170281789A1
Human necessities

Photodynamic therapy composition

#1179 ✅ Patent 10,385,113 granted on 2019-08-20
US20170281790A1
Human necessities

Engineered FGF compositions and methods of use thereof

#1180
US20170281791A1
Human necessities

ANTI-TROP-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

#1181 ✅ Patent 10,022,452 granted on 2018-07-17
US20170281792A1
Human necessities

Anti-mesothelin antibodies and immunoconjugates

#1182 ✅ Patent 10,160,809 granted on 2018-12-25
US20170281793A1
Human necessities

Anti-TEM1 antibodies and uses thereof

#1183 ✅ Patent 10,098,963 granted on 2018-10-16
US20170281794A1
Human necessities

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates

#1184
US20170281795A1
Human necessities

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

#1185
US20170281796A1
Human necessities

c-Met Antibody Drug Conjugate

#1186 ✅ Patent 10,828,083 granted on 2020-11-10
US20170281797A1
Human necessities

Lactoferrin-conjugated nanoparticle complex and use thereof

#1187
US20170281798A1
Human necessities

Synthetic Scaffolds for Metastasis Detection

#1188
US20170281799A1
Human necessities

SYSTEMS AND METHODS FOR SCREENING OTOTOXIC, OTOPROTECTIVE, AND OTOREGENERATIVE COMPOUNDS USING AQUATIC MODELS

#1189 ✅ Patent 9,782,497 granted on 2017-10-10
US20170281800A9
Human necessities

Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors

#1190 ✅ Patent 9,968,691 granted on 2018-05-15
US20170281801A1
Human necessities

PSMA-targeted NIR dyes and their uses

#1191 ✅ Patent 10,709,801 granted on 2020-07-14
US20170281802A1
Human necessities

Targeting corroles for tumor toxicity and MRI

#1192
US20170281803A1
Human necessities

RENAL IMAGING AGENT

#1193 ✅ Patent 11,071,793 granted on 2021-07-27
US20170281804A1
Human necessities

Probes for imaging huntingtin protein

#1194 ✅ Patent 10,561,748 granted on 2020-02-18
US20170281805A1
Human necessities

Anthranilic acid derivatives

#1195
US20170281806A1
Human necessities

CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING

#1196 ✅ Patent 10,213,506 granted on 2019-02-26
US20170281807A1
Human necessities

Targeting immunotherapy for amyloidosis

#1197 ✅ Patent 10,000,573 granted on 2018-06-19
US20170281808A1
Human necessities

Monoclonal antibody and a method thereof

#1198
US20170281809A1
Human necessities

ANTI-NKG2A ANTIBODIES AND USES THEREOF

#1199 ✅ Patent 10,098,900 granted on 2018-10-16
US20170281810A1
Human necessities

Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases

#1200 ✅ Patent 9,795,700 granted on 2017-10-24
US20170281811A1
Human necessities

Countertop decontaminating device